| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |